Second Report Documents Industrys Intense Lobby and Political Contribution Campaign to Keep Prices and Profits High - The pharmaceutical industry spends about one-fifth of what it says it spends on the research and development (R&D) of new drugs, destroying the chief argument it uses against making prescription drugs affordable to middle and low-income seniors, a Public Citizen investigation has found.